Opens in a new tab

Syntorr LP v Arthrex (CoA, UPC_CoA_890/2025, 18 February 2026)

Date18 February 2026
CourtCoA
DivisionLuxembourg (LU)
Type of actionApplication For Costs
Case number(s)UPC_CoA_890/2025
Registry referenceUPC-COA-0000890/2025
PartiesSyntorr LP v. Arthrex Inc., Arthrex GmbH, Arthrex Distribution Hub EMEA B.V.

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By order of 18 February 2026 (UPC_CoA_890/2025), the Court of Appeal, on discretionary review, set aside the Munich Local Division’s orders requiring Syntorr, claimant in an infringement action on EP 2 670 898 against three Arthrex companies, to provide security for costs of EUR 2,000,000. It dismissed the request for security and ordered the release of the bank guarantee provided. The decision matters for funded claimants: litigation insurance with an anti-avoidance endorsement may remove any legitimate concern that costs will not be recovered.

Question

Must an insurance policy covering the defendant’s costs, made non-cancellable and non-voidable by a specific endorsement, be taken into account when assessing the claimant’s financial position under Art. 69(4) UPCA and Rule 158.1 RoP?

Decision

Security is meant to protect a defendant against a claimant without sufficient means (paragraph 17), the court asks whether the claimant’s financial position gives rise to a legitimate and real concern that a costs order may not be recoverable, or only in an unduly burdensome way (paragraph 19), the burden of substantiation lying on the applicant (paragraph 20). The insurance policy forms part of that financial position (paragraph 25). Syntorr sufficiently established its validity, with a limit of EUR 4,000,000 (paragraphs 26 to 28), the endorsement makes the policy non-voidable and non-cancellable up to that limit and the defendants can enforce it directly (paragraphs 29 and 30), the payment procedure is straightforward (paragraph 31) and the insurer, established in the Union, is subject to Solvency II (paragraph 34). There was no legitimate concern, so security was not necessary (paragraph 35), and the guarantee was released by analogy with Rule 352.2 RoP (paragraph 37).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 69(4)
Rules of Procedure
Rules 158.1, 220.3, 220.4, 333 and 352
Other provisions
Directive 2009/138/EC (Solvency II)
Case law cited
ICPillar v ARM, Court of Appeal, 16 September 2024, AorticLab v Emboline, Court of Appeal, 20 June 2025, Audi v Network System Technologies, Court of Appeal, 17 September 2024, Volkswagen v Network System Technologies, Court of Appeal, 17 September 2024, Chint v JingAo, Court of Appeal, 9 July 2025, Suinno v Microsoft, Court of Appeal, 12 July 2025, Oerlikon v Bhagat, Court of Appeal, 30 October 2025

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: UPC Court of Appeal, Court fees and costs (UPC).

Dhenne Avocats blog: UPC Appeals: What the Numbers Show.

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CoA_890/2025 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Application For Costs
Outcome (Dhenne Avocats summary)
La cour d'appel annule la garantie de 2 000 000 euros imposée à Syntorr, son assurance couvrant les frais adverses, non résiliable et directement invocable, écartant toute crainte légitime de non-recouvrement.
Appeal
Decision of the Court of Appeal.
Instance
Court of Appeal decision.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 2 670 898Mentioned in the analysis (role not qualified)
Also mentioned in 1 other decision(s): Syntorr v Arthrex (CFI, ORD_25293/2025, 11 August 2025)
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.